Kinzi Self
Nurse Practitioner · Fort Worth, TXNPI 1932948189
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 26.8% of the total.
Across 76 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$451
- Biogen$197
- Johnson & Johnson$137
- TG Therapeutics, Inc.$86
- Neurocrine Biosciences, Inc.$75
- Takeda Pharmaceuticals U.S.A., Inc.$64
- plus $674 from 23 others
What the payments were for
- Food & beverage$1,58494%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $451 |
| Biogen | 10 | $197 |
| Johnson & Johnson | 3 | $137 |
| TG Therapeutics, Inc. | 3 | $86 |
| Neurocrine Biosciences, Inc. | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Eisai Inc. | 2 | $55 |
| EMD Serono, Inc. | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Tersera Therapeutics LLC | 2 | $40 |
| UCB, Inc. | 2 | $38 |
| Acadia Pharmaceuticals Inc | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Sandoz | 1 | $27 |
| Sanofi | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Cala Health, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Invivyd Inc | 1 | $21 |
| Tanabe Pharma America, Inc. | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| Argenx US, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,684 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Fort Worth
- Deborah StapelFort Worth$44K
- Jessica RothFort Worth$15K
- Kathryn MorelandFort Worth$15K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.